Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Women's Assessed Cardiovascular Evaluation With MCG

NCT04739280 is registered in ClinicalTrials.gov with Genetesis Inc. as lead sponsor.

NCT NCT04739280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04739280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Women's Assessed Cardiovascular Evaluation With MCG
Lead sponsor
Genetesis Inc.
Phase
Observational
Overall status
Completed
Start date
October 15, 2020
Completion date
July 21, 2022
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac disease, ischemia, risk factor, cardiovascular